Already a member? Click here to login.
Already a member? Click here to login.
15 June 2016
The Australian Diabetes Educators Association (ADEA) commends the Labor Party’s commitment to invest in continuous glucose monitoring (CGM) technology and insulin pump program:
There are currently 13,600 children and young adults under 21 with type 1 diabetes.
They are required to monitor their glucose levels multiple times a day by pricking their fingers otherwise they risk both short and long term complications including injury, lasting damage or even death.
A CGM device provides continuous, 24-hour per day, monitoring of a person’s glucose levels and can improve the quality of life especially for people at risk of hypoglycaemia.
Labor’s promised investment will result in removing cost barriers to people with diabetes who will most benefit from this technology.
The expansion of the Insulin Pump Therapy program will make insulin pump therapy more accessible, providing 200 pumps each year.
Credentialled diabetes educators are best equipped to educate people with diabetes in pump therapy and continuous glucose monitoring, assisting the Labor’s plan to improve the quality of life and productivity of people with type 1 diabetes.
Dr Joanne Ramadge, ADEA CEO, says ‘this is an important commitment that will help many Australian with diabetes. ADEA is pleased that diabetes is prioritised as a significant election issue’.
-end-
Media contact: Vy Le | vy.le@adea.com.au | 02 6173 1009 | 0401 066 554
15 June 2016
The Australian Diabetes Educators Association (ADEA) commends the Labor Party’s commitment to invest in continuous glucose monitoring (CGM) technology and insulin pump program:
There are currently 13,600 children and young adults under 21 with type 1 diabetes.
They are required to monitor their glucose levels multiple times a day by pricking their fingers otherwise they risk both short and long term complications including injury, lasting damage or even death.
A CGM device provides continuous, 24-hour per day, monitoring of a person’s glucose levels and can improve the quality of life especially for people at risk of hypoglycaemia.
Labor’s promised investment will result in removing cost barriers to people with diabetes who will most benefit from this technology.
The expansion of the Insulin Pump Therapy program will make insulin pump therapy more accessible, providing 200 pumps each year.
Credentialled diabetes educators are best equipped to educate people with diabetes in pump therapy and continuous glucose monitoring, assisting the Labor’s plan to improve the quality of life and productivity of people with type 1 diabetes.
Dr Joanne Ramadge, ADEA CEO, says ‘this is an important commitment that will help many Australian with diabetes. ADEA is pleased that diabetes is prioritised as a significant election issue’.
-end-
Media contact: Vy Le | vy.le@adea.com.au | 02 6173 1009 | 0401 066 554
